Locanabio is creating a new class of gene therapies able to modify dysfunctional RNA associated with a range of severe disorders including neuromuscular, neurodegenerative and retinal diseases. Our multi-functional approach is engineered to produce unique gene therapies which deliver RNA binding proteins and effector domains that target RNA across multiple mechanisms of action necessary to restore or improve health and make a ...
Locanabio is creating a new class of gene therapies able to modify dysfunctional RNA associated with a range of severe disorders including neuromuscular, neurodegenerative and retinal diseases. Our multi-functional approach is engineered to produce unique gene therapies which deliver RNA binding proteins and effector domains that target RNA across multiple mechanisms of action necessary to restore or improve health and make a meaningful difference in patients’ lives. Creating a new class of gene therapies by targeting disease-causing messenger RNA. We are working hard to realize the potential of RNA-targeting gene therapy to treat a range.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.